Key filings, July 10, 2026

ContractFaduKOSDAQ

Contract value

₩42.1B

Of revenue

45.5%

Worth 45.5% of last year's revenue, over about 7 months.

2026-07-10 – 2027-01-30

ContractiCRAFTKOSDAQ

Contract value

₩45.4B

Of revenue

22%

Worth 22% of last year's revenue, over about 66 months.

2026-07-08 – 2031-12-31

EarningsSena TechnologiesKOSDAQ

Operating profit

₩18B

YoY

+127.6%

Operating profit ₩18B, up 127.6% YoY. Revenue ₩75.5B, up 40.3% YoY.

Q2 2026 · Separate

5% holderNew 5%Lemon HealthcareKOSDAQ

Stake

31.51%

Change

+31.51pp

A major holder's stake rose from 0.00% to 31.51% (new report).

5% holderNew 5%Eone Diagnomics Genome CenterKOSDAQ

Stake

9.21%

Change

+9.21pp

A major holder's stake rose from 0.00% to 9.21%.

5% holderNew 5%Oneul E&MKOSDAQ

Stake

5.92%

Change

+5.92pp

A major holder's stake rose from 0.00% to 5.92% (new report).

IssuanceCapital reductionGood PeopleKOSDAQ

Reduction

80%

Capital reduction of 80%.

IssuanceCapital reductionFreeTKOSPI

Reduction

40%

Capital reduction of 40%.

Supply contracts 20

7/10AmendedTelcon RF Pharmaceutical Worth 181.2% of last year's revenue, over about 120 months.₩54.1B

7/10Exicon Worth 75.5% of last year's revenue, over about 6 months.₩49.9B

7/10Fadu Worth 45.5% of last year's revenue, over about 7 months.₩42.1B

7/10AmendedBHI Worth 40.4% of last year's revenue, over about 31 months.₩148B

7/10AmendedBHI Worth 38.3% of last year's revenue, over about 33 months.₩141B

7/10AmendedKoses Worth 27.3% of last year's revenue, over about 14 months.₩18.9B

7/10AmendedIlsung Construction Worth 22.9% of last year's revenue, over about 62 months.₩78.3B

7/10iCRAFT Worth 22% of last year's revenue, over about 66 months.₩45.4B

7/10AmendedWoowon Development Worth 20.7% of last year's revenue, over about 56 months.₩40.6B

7/10Amendeddotmill Worth 15.4% of last year's revenue, over about 11 months.₩3.6B

7/10AmendedDongwonDevelopment Worth 15% of last year's revenue, over about 95 months.₩96.5B

7/10AmendedDong-A Pharmaceutical Worth 15% of last year's revenue, over about 12 months.₩8.8B

7/10AmendedHyundai Engineering & Construction Worth 14.6% of last year's revenue, over about 48 months.₩3.09T

7/10AmendedYooshin Engineering Worth 11.8% of last year's revenue, over about 16 months.₩40B

7/10Hanwha Engine Worth 8.4% of last year's revenue, over about 38 months.₩116B

7/10AmendedYooshin Engineering Worth 6.4% of last year's revenue, over about 42 months.₩19.6B

7/10AmendedSghealthcare Worth 5.4% of last year's revenue, over about 17 months.₩1.5B

7/10DL Holdings Worth 3.5% of last year's revenue, over about 128 months.₩258B

7/10DL E&C Worth 3.5% of last year's revenue, over about 128 months.₩258B

7/10AmendedKye-Ryong Construction Industrial Worth 3.1% of last year's revenue, over about 35 months.₩91.8B

Preliminary earnings 1

7/10Sena Technologies Operating profit ₩18B, up 127.6% YoY. Revenue ₩75.5B, up 40.3% YoY.₩18B

Insider trades 89

7/10Alticast Insider ownership report

7/10A Plus Asset Advisor Insider ownership report

7/10NextEye Insider ownership report

7/10OSP Insider ownership report

7/10Sajodaerim Insider ownership report

7/10EugeneTechnology Insider ownership report

7/10SKAI worldwide Insider ownership report

7/10Daesung Private Equity Insider ownership report

7/10GFI Insider ownership report

7/10CTR Mobility Insider ownership report

7/10KR Motors Insider ownership report

7/10Celltrion Insider ownership report

7/10Seojin System Insider ownership report

7/10Dongsung Chemical Insider ownership report

7/10KR Motors Insider ownership report

7/10Yuanta Securities Korea Insider ownership report

7/10NeoImmuneTech Insider ownership report

7/10AmendedNGeneBio Insider ownership report

7/10Alton Insider ownership report

7/10Lemon Healthcare Insider ownership report